Related Experiment Video

Updated: Aug 11, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.6K

The evolution and impact of the American College of Chest Physicians consensus statement on antithrombotic therapy

Victor F Tapson1

  • 1Division of Pulmonary and Critical Care, Box 31175, Room 351, Bell Building, Duke University Medical Center, Durham, NC 27710, USA. tapso001@mc.duke.edu

Clinics in Chest Medicine
|April 11, 2003
PubMed

Insights

This review examines the evolution of American College of Chest Physicians guidelines for antithrombotic therapy in venous thromboembolism prevention and treatment. It discusses the evidence base and the impact of these crucial recommendations.

Area of Science:

  • Cardiology
  • Hematology
  • Clinical Guidelines

Background:

  • Antithrombotic therapy is critical for managing venous thromboembolism (VTE).
  • The American College of Chest Physicians (CHEST) provides influential consensus guidelines.
  • Previous guidelines have evolved based on new evidence.

Purpose of the Study:

  • To review the historical development of CHEST consensus on antithrombotic therapy for VTE.
  • To analyze the evidence-based approach used in formulating these recommendations.
  • To offer a perspective on the clinical impact of the CHEST guidelines.

Main Methods:

  • Literature review of CHEST consensus statements on antithrombotic therapy.
  • Analysis of the evidence grading and application within the guidelines.
  • Synthesis of expert opinion and clinical experience.

Main Results:

  • The CHEST guidelines for VTE prevention and treatment have undergone significant evolution.
  • A rigorous evidence-based methodology underpins the recommendations.
  • The guidelines have substantially influenced clinical practice and patient outcomes.

Conclusions:

  • The evolution of CHEST guidelines reflects advancements in understanding VTE and antithrombotic agents.
  • Adherence to evidence-based recommendations is key for effective VTE management.
  • The impact of these guidelines on patient care is profound and ongoing.

More Related Videos

Transaxillary First Rib Resection for Treatment of the Thoracic Outlet Syndrome06:57

Transaxillary First Rib Resection for Treatment of the Thoracic Outlet Syndrome

Published on: September 13, 2020

3.8K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.7K

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...